Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Relapse is common among patients with systemic polyarteritis nodosa, with mycophenolate performing similarly to cyclophosphamide.